Global Market Study on Immuno-Oncology: Immune Checkpoint Inhibitors Segment Projected to be the Most Lucrative Segment by Therapy Type

Sep 2019| PMR230B| Persistence Market Research

Report Highlights

Persistence Market Research (PMR) recently published a market study on the global market for immune-oncology. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the immuno-oncology market structure. The market study presents exclusive information about how the immuno-oncology market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the immuno-oncology market during the forecast period.

The study is relevant for stakeholders in the immuno-oncology market, including immuno-oncology therapy manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the immuno-oncology market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the immuno-oncology market. Furthermore, small businesses and new entrants in the immuno-oncology market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Key Questions Answered in PMR’s Immuno-Oncology Market Report

Which regions will continue to remain the most profitable regional markets for immuno-oncology market players?
Which factors will induce a change in the demand for immuno-oncology therapy during the assessment period?
How will changing trends impact the immuno-oncology market?
How can market players capture the low-hanging opportunities in the immuno-oncology market in developed regions?
Which companies are leading the immuno-oncology market?
What are the winning strategies of stakeholders in the immuno-oncology market to upscale their position in this landscape?
Immuno-Oncology Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the immuno-oncology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to analysts during the production of the immuno-oncology market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the immuno-oncology market, and makes PMR’s projection on the growth prospects of the immuno-oncology market more accurate and reliable.

  • Table 1 : Immuno-Oncology Market Value (US$ Mn) Growth Comparison
  • Table 2 : Global Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapy
  • Table 3 : Global Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapeutic Area
  • Table 4 : Global Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 5 : Global Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
  • Table 6 : North America Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 7 : North America Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapy
  • Table 8 : North America Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapeutic Area
  • Table 9 : North America Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 10 : Latin America Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 11 : Latin America Immuno-Oncology Market Size(US$Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapy
  • Table 12 : Latin America Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapeutic Area
  • Table 13 : Latin America Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 14 : Europe Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 15 : Europe Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapy
  • Table 16 : Europe Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapeutic Area
  • Table 17 : Europe Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 18 : Asia Pacific Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 19 : Asia Pacific Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapy
  • Table 20 : Asia Pacific Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapeutic Area
  • Table 21 : Asia Pacific Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 22 : Middle East and Africa Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 23 : Middle East and Africa Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapy
  • Table 24 : Middle East and Africa Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapeutic Area
  • Table 25 : Middle East and Africa Immuno-Oncology Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 1 : Global Immuno-Oncology Market Revenue Split by Therapy (2019)
  • Figure 2 : Global Immuno-Oncology Market Revenue Split by Therapeutic Area (2019)
  • Figure 3 : Global Immuno-Oncology Market Revenue Split by End User (2019)
  • Figure 4 : Global Immuno-Oncology Market Revenue Split by Region (2019)
  • Figure 5 : Global Immuno-Oncology Market Value Analysis (US$ Mn), 2014-2018
  • Figure 6 : Global Immuno-Oncology Market Value Forecast (US$ Mn), 2019-2029
  • Figure 7 : Global Immuno-Oncology Market Absolute $ Opportunity, 2019-2029
  • Figure 8 : Comparison September 2017 and September 2019, Y-o-Y Forecast
  • Figure 9 : Global Immuno-Oncology Market Share Analysis (%), By Therapy, 2019 & 2029
  • Figure 10 : Global Immuno-Oncology Market Y-o-Y Analysis (%), By Therapy, 2019-2029
  • Figure 11 : Global Immuno-Oncology Market Share Analysis (%), By Therapy, (2014-2018)
  • Figure 12 : Global Immuno-Oncology Market Share Forecast (%), By Therapy, (2018-2029)
  • Figure 13 : Global Immuno-Oncology Market Attractiveness Analysis By Therapy, 2019-2029
  • Figure 14 : Global Immuno-Oncology Market Share Analysis (%), By Therapeutic Area, 2019 & 2029
  • Figure 15 : Global Immuno-Oncology Market Y-o-Y Analysis (%), By Therapeutic Area, 2019-2029
  • Figure 16 : Global Immuno-Oncology Market Share Analysis (%), By Therapeutic Area, (2014-2018)
  • Figure 17 : Global Immuno-Oncology Market Share Forecast (%), By Therapeutic Area, (2018-2029)
  • Figure 18 : Global Immuno-Oncology Market Attractiveness Analysis By Therapeutic Area, 2019-2029
  • Figure 19 : Global Immuno-Oncology Market Share Analysis (%), By End User, 2019 & 2029
  • Figure 20 : Global Immuno-Oncology Market Y-o-Y Analysis (%), By End User, 2019-2029
  • Figure 21 : Global Immuno-Oncology Market Share Analysis (%), By End User, (2014-2018)
  • Figure 22 : Global Immuno-Oncology Market Share Forecast (%), By End User, (2018-2029)
  • Figure 23 : Global Immuno-Oncology Market Attractiveness Analysis By End User, 2019-2029
  • Figure 24 : Global Immuno-Oncology Market Share Analysis (%), By Region, 2019 & 2029
  • Figure 25 : Global Immuno-Oncology Market Y-o-Y Analysis (%), By Region, 2019-2029
  • Figure 26 : Global Immuno-Oncology Market Share Analysis (%), By Region, (2014-2018)
  • Figure 27 : Global Immuno-Oncology Market Share Forecast (%), By Region, (2018-2029)
  • Figure 28 : Global Immuno-Oncology Market Attractiveness Analysis By Region, 2019-2029
  • Figure 29 : North America Immuno-Oncology Market Value Share, By Therapy, 2019 (E)
  • Figure 30 : North America Immuno-Oncology Market Value Share, By Therapeutic area, 2019 (E)
  • Figure 31 : North America Immuno-Oncology Market Value Share, By End User, 2019 (E)
  • Figure 32 : North America Immuno-Oncology Market Value Share, By Country, 2019 (E)
  • Figure 33 : North America Immuno-Oncology Market Value Analysis (US$ Mn), 2014-2018
  • Figure 34 : North America Immuno-Oncology Market Value Forecast (US$ Mn), 2019-2029
  • Figure 35 : North America Immuno-Oncology Market Attractiveness Analysis By Therapy, 2019-2029
  • Figure 36 : North America Immuno-Oncology Market Attractiveness Analysis By Therapeutic Area, 2019-2029
  • Figure 37 : North America Immuno-Oncology Market Attractiveness Analysis By End User, 2019-2029
  • Figure 38 : North America Immuno-Oncology Market Attractiveness Analysis By Country, 2019-2029
  • Figure 39 : Latin America Immuno-Oncology Market Value Share, By Therapy, 2019 (E)
  • Figure 40 : Latin America Immuno-Oncology Market Value Share, By Therapeutic area, 2019 (E)
  • Figure 41 : Latin America Immuno-Oncology Market Value Share, By End User, 2019 (E)
  • Figure 42 : Latin America Immuno-Oncology Market Value Share, By Country, 2019 (E)
  • Figure 43 : Latin America Immuno-Oncology Market Value Analysis (US$ Mn), 2014-2018
  • Figure 44 : Latin America Immuno-Oncology Market Value Forecast (US$ Mn), 2019-2029
  • Figure 45 : Latin America Immuno-Oncology Market Attractiveness Analysis By Therapy, 2019-2029
  • Figure 46 : Latin America Immuno-Oncology Market Attractiveness Analysis By Therapeutic Area, 2019-2029
  • Figure 47 : Latin America Immuno-Oncology Market Attractiveness Analysis By End User, 2019-2029
  • Figure 48 : Latin America Immuno-Oncology Market Attractiveness Analysis By Country, 2019-2029
  • Figure 49 : Europe Immuno-Oncology Market Value Share, By Therapy, 2019 (E)
  • Figure 50 : Europe Immuno-Oncology Market Value Share, By Therapeutic area, 2019 (E)
  • Figure 51 : Europe Immuno-Oncology Market Value Share, By End User, 2019 (E)
  • Figure 52 : Europe Immuno-Oncology Market Value Share, By Country, 2019 (E)
  • Figure 53 : Europe Immuno-Oncology Market Value Analysis (US$ Mn), 2014-2018
  • Figure 54 : Europe Immuno-Oncology Market Value Forecast (US$ Mn), 2019-2029
  • Figure 55 : Europe Immuno-Oncology Market Attractiveness Analysis By Therapy, 2019-2029
  • Figure 56 : Europe Immuno-Oncology Market Attractiveness Analysis By Therapeutic Area, 2019-2029
  • Figure 57 : Europe Immuno-Oncology Market Attractiveness Analysis By End User, 2019-2029
  • Figure 58 : Europe Immuno-Oncology Market Attractiveness Analysis By Country, 2019-2029
  • Figure 59 : Asia Pacific Immuno-Oncology Market Value Share, By Therapy, 2019 (E)
  • Figure 60 : Asia Pacific Immuno-Oncology Market Value Share, By Therapeutic area, 2019 (E)
  • Figure 61 : Asia Pacific Immuno-Oncology Market Value Share, By End User, 2019 (E)
  • Figure 62 : Asia Pacific Immuno-Oncology Market Value Share, By Country, 2019 (E)
  • Figure 63 : Asia Pacific Immuno-Oncology Market Value Analysis (US$ Mn), 2014-2018
  • Figure 64 : Asia Pacific Immuno-Oncology Market Value Forecast (US$ Mn), 2019-2029
  • Figure 65 : Asia Pacific Immuno-Oncology Market Attractiveness Analysis By Therapy, 2019-2029
  • Figure 66 : Asia Pacific Immuno-Oncology Market Attractiveness Analysis By Therapeutic Area, 2019-2029
  • Figure 67 : Asia Pacific Immuno-Oncology Market Attractiveness Analysis By End User, 2019-2029
  • Figure 68 : Asia Pacific Immuno-Oncology Market Attractiveness Analysis By Country, 2019-2029
  • Figure 69 : MEA Immuno-Oncology Market Value Share, By Therapy, 2019 (E)
  • Figure 70 : MEA Immuno-Oncology Market Value Share, By Therapeutic area, 2019 (E)
  • Figure 71 : MEA Immuno-Oncology Market Value Share, By End User, 2019 (E)
  • Figure 72 : MEA Immuno-Oncology Market Value Share, By Country, 2019 (E)
  • Figure 73 : Middle East and Africa Immuno-Oncology Market Value Analysis (US$ Mn), 2014-2018
  • Figure 74 : Middle East and Africa Immuno-Oncology Market Value Forecast (US$ Mn), 2019-2029
  • Figure 75 : Middle East and Africa Immuno-Oncology Market Attractiveness Analysis By Therapy, 2019-2029
  • Figure 76 : Middle East and Africa Immuno-Oncology Market Attractiveness Analysis By Therapeutic Area, 2019-2029
  • Figure 77 : Middle East and Africa Immuno-Oncology Market Attractiveness Analysis By End User, 2019-2029
  • Figure 78 : Middle East and Africa Immuno-Oncology Market Attractiveness Analysis By Country, 2019-2029

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report